From diagnosis to patient well-being
Founded in Lyon, France, LDBIO Diagnostics is an independent pharmaceutical company dedicated to the development, production and marketing of in vitro diagnosis offering infectious diseases testing solutions.
Our history, our expertise
LDBIO Diagnostics was founded in 1998 on the basis of the development of confirmatory serological tests in parasitology and mycology, using Western Blot technology and natural antigens. Beginning with the provision of a test for the post-natal diagnosis of congenital toxoplasmosis, the offer was gradually extended to various diseases. We have thus been able to build up a relationship of trust with numerous specialised laboratories.
Wishing to offer an ambulatory diagnostic test dedicated to use as close as possible to the patient, LDBIO Diagnostics team also developed rapid immuno-chromatographic tests (ICT) for the detection of parasitic and fungal diseases. They are offered to a wider range of professionals, not necessarily equipped and trained in conventional laboratory biology.
Our vision, our values
Committed to specialists in the hospital world, our activity is motivated by the improvement of patient care and well-being.
LDBIO Diagnostics’ development strategy implies close relationships with its partners and customers, both French and foreign, as well as a sustained attention to all aspects related to the quality and performance controls of its products in order to be able to offer the best possible diagnostic tool.
It also implies a particular interest in certain orphan diseases, outside the market of reagents usually encountered and for which there are often few tests available.
We are committed to offering an impeccable quality of products and services. The development, production, marketing and distribution of our products are entirely controlled by our laboratory.
In this way, our company perpetuates the values that have guided it from the outset: innovation, high standards, professionalism, commitment and partnership.